NEW YORK, December 21, 2025 – A seemingly innocuous bruise at the base of a newborn’s umbilical cord-an umbilical hematoma-can sometimes signal a serious underlying bleeding disorder. The primary investigation for an umbilical hematoma in a newborn is a comprehensive coagulation panel, including factor XIII levels.
Understanding Umbilical hematomas and Bleeding Risks
Umbilical hematomas, while frequently enough benign, necessitate a thorough medical evaluation to exclude potentially life-threatening coagulation deficiencies.
- umbilical hematomas can be a sign of a bleeding disorder.
- A comprehensive coagulation panel is the first step in diagnosis.
- Factor XIII deficiency is a key condition to rule out.
- Prompt diagnosis and treatment are crucial for managing bleeding risks.
The concern stems from the possibility of inherited bleeding disorders. While most umbilical hematomas resolve on their own, a persistent or unusually large hematoma warrants investigation. A quick assessment can provide peace of mind, or, more importantly, identify a condition requiring immediate intervention.
The Role of Coagulation Panels
When a healthcare provider suspects a bleeding disorder,a coagulation panel is ordered. This series of blood tests assesses the function of various clotting factors-proteins essential for stopping bleeding. These factors work in a cascade, and a deficiency in any one can lead to excessive bleeding
